Joon Yeul Nam

1.0k total citations
32 papers, 582 citations indexed

About

Joon Yeul Nam is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Joon Yeul Nam has authored 32 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 24 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Joon Yeul Nam's work include Liver Disease Diagnosis and Treatment (20 papers), Hepatitis B Virus Studies (19 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). Joon Yeul Nam is often cited by papers focused on Liver Disease Diagnosis and Treatment (20 papers), Hepatitis B Virus Studies (19 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). Joon Yeul Nam collaborates with scholars based in South Korea, Ethiopia and Puerto Rico. Joon Yeul Nam's co-authors include Jeong‐Hoon Lee, Jung‐Hwan Yoon, Yoon Jun Kim, Su Jong Yu, Eun Ju Cho, Young Woon Chang, Young Youn Cho, Hyeki Cho, Yun Bin Lee and Jeong Min Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Joon Yeul Nam

32 papers receiving 577 citations

Peers

Joon Yeul Nam
Azusa Sakamoto Japan
Miao Shan Lim Singapore
Alvaro Koch United States
Norihiro Imai Japan
Yohji Honda Japan
Mohamed Shoreibah United States
Jong Ryul Eun South Korea
Benyam D. Addissie United States
Ciro Celsa Italy
Roxanne Desiderio United States
Azusa Sakamoto Japan
Joon Yeul Nam
Citations per year, relative to Joon Yeul Nam Joon Yeul Nam (= 1×) peers Azusa Sakamoto

Countries citing papers authored by Joon Yeul Nam

Since Specialization
Citations

This map shows the geographic impact of Joon Yeul Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joon Yeul Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joon Yeul Nam more than expected).

Fields of papers citing papers by Joon Yeul Nam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joon Yeul Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joon Yeul Nam. The network helps show where Joon Yeul Nam may publish in the future.

Co-authorship network of co-authors of Joon Yeul Nam

This figure shows the co-authorship network connecting the top 25 collaborators of Joon Yeul Nam. A scholar is included among the top collaborators of Joon Yeul Nam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joon Yeul Nam. Joon Yeul Nam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Yun Bin, Joon Yeul Nam, Eun Ju Cho, et al.. (2023). A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma. Clinical Cancer Research. 29(18). 3650–3658. 31 indexed citations
3.
Jang, Heejoon, Yun Bin Lee, Jong‐Won Chung, et al.. (2022). Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis. Hepatology. 76(2). 492–501. 27 indexed citations
4.
Park, Min Kyung, Yun Bin Lee, Heejoon Jang, et al.. (2022). Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation. Digestive Diseases and Sciences. 67(10). 4939–4949. 8 indexed citations
5.
Jang, Heejoon, Joon Yeul Nam, Yun Bin Lee, et al.. (2021). Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study. SHILAP Revista de lepidopterología. Volume 8. 1565–1577. 11 indexed citations
6.
Chung, Sung Won, Min Kyung Park, Young Youn Cho, et al.. (2021). Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of Hepatocellular Carcinoma. Volume 8. 587–598. 2 indexed citations
7.
Nam, Joon Yeul, Yun Bin Lee, Jeong‐Hoon Lee, et al.. (2021). A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC. Digestive Diseases and Sciences. 67(1). 329–336. 6 indexed citations
8.
Nam, Joon Yeul, Hyung Jin Chung, Kyu Sung Choi, et al.. (2021). Deep learning model for diagnosing gastric mucosal lesions using endoscopic images: development, validation, and method comparison. Gastrointestinal Endoscopy. 95(2). 258–268.e10. 28 indexed citations
9.
Nam, Joon Yeul, Dong Hyun Sinn, Jun Ho Bae, et al.. (2020). Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy. JHEP Reports. 2(6). 100175–100175. 29 indexed citations
10.
Nam, Joon Yeul, A Reum Choe, Dong Hyun Sinn, et al.. (2020). A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function. BMC Cancer. 20(1). 504–504. 20 indexed citations
11.
Yoon, Jun Sik, Dong Hyun Sinn, Jeong‐Hoon Lee, et al.. (2019). Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study. Cancers. 11(11). 1721–1721. 6 indexed citations
12.
Cho, Hyeki, Dong Ho Lee, Jeong‐Hoon Lee, et al.. (2018). Entecavir and tenofovir reduce hepatitis B virus‐related hepatocellular carcinoma recurrence more effectively than other antivirals. Journal of Viral Hepatitis. 25(6). 707–717. 19 indexed citations
13.
Kim, Hwi Young, Joon Yeul Nam, Jeong‐Hoon Lee, et al.. (2018). Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B‐endemic area. Alimentary Pharmacology & Therapeutics. 47(11). 1490–1501. 15 indexed citations
14.
Lee, Minjong, Young Woon Chang, Sohee Oh, et al.. (2018). Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification. Gut and Liver. 12(5). 571–582. 9 indexed citations
15.
Lee, Yun Bin, Joon Yeul Nam, Jeong‐Hoon Lee, et al.. (2018). Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality. Scientific Reports. 8(1). 13651–13651. 10 indexed citations
16.
Cho, Young Youn, Jeong‐Hoon Lee, Young Woon Chang, et al.. (2018). Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients. Journal of Viral Hepatitis. 25(10). 1161–1171. 15 indexed citations
17.
Kang, Seong Hee, Yun Bin Lee, Jeong‐Hoon Lee, et al.. (2017). Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Alimentary Pharmacology & Therapeutics. 46(9). 845–855. 61 indexed citations
18.
Nam, Joon Yeul, Jeong‐Hoon Lee, Hwi Young Kim, et al.. (2017). Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients. PLoS ONE. 12(1). e0166188–e0166188. 9 indexed citations
19.
Yoo, Jeong‐Ju, Goh Eun Chung, Jeong‐Hoon Lee, et al.. (2017). Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib. Cancer Research and Treatment. 50(2). 366–373. 16 indexed citations
20.
Lee, Minjong, Ara Jo, Seulki Lee, et al.. (2017). 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells. PLoS ONE. 12(3). e0174271–e0174271. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Azusa Sakamoto Breakdown of academic impact, for papers by Miao Shan Lim Breakdown of academic impact, for papers by Alvaro Koch Breakdown of academic impact, for papers by Norihiro Imai Breakdown of academic impact, for papers by Yohji Honda Breakdown of academic impact, for papers by Mohamed Shoreibah Breakdown of academic impact, for papers by Jong Ryul Eun Breakdown of academic impact, for papers by Benyam D. Addissie Breakdown of academic impact, for papers by Ciro Celsa Breakdown of academic impact, for papers by Roxanne Desiderio
Rankless by CCL
2026